TeraCyte Analytics
Gal Lenz is currently the CTO and Co-Founder at TeraCyte Analytics, with previous experience as a Project Manager and Postdoctoral Fellow at City of Hope. Before that, they were a PhD student at Tel Aviv University and also worked as a lecturer and CEO at Your Teacher.co.il. Gal's research focuses on the development of drug resistance in human breast cancer cell lines and the link between metabolism and resistance, as well as the complex regulations of RNA chaperon CspC.
This person is not in any teams
This person is not in any offices
TeraCyte Analytics
Our breakthrough Array Cytometry (TM) technology introduces large-scale acquisition of dynamic single-cell responses. TeraCyte’s world-renowned team of system biologists, computational biologists and data experts will use this dynamic data to build predictive models and applications and streamline drug development.